curacle co.,ltd. (KOSDAQ:365270)
South Korea · Delayed Price · Currency is KRW 8,330.00
-520.00 (-5.88%)
At close: Jul 20, 2026
curacle co.,ltd. Market Cap
curacle co.,ltd. has a market cap or net worth of 177.46 billion as of July 20, 2026. Its market cap has increased by 132.43% in one year.
Market Cap
177.46B
Enterprise Value
169.15B
Revenue
1.06B
Ranking
n/a
PE Ratio
n/a
Stock Price
8,330.00
ChartMarket Cap Chart
Since July 22, 2021, curacle co.,ltd.'s market cap has decreased from 409.36B to 177.46B, a decrease of -56.65%. That is a compound annual growth rate of -15.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 177.46B | 18.47% |
| Dec 30, 2025 | 149.80B | 79.35% |
| Dec 30, 2024 | 83.52B | -48.17% |
| Dec 28, 2023 | 161.14B | 2.54% |
| Dec 29, 2022 | 157.15B | -49.31% |
| Dec 30, 2021 | 310.02B | -24.27% |
| Jul 22, 2021 | 409.36B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| IMBiologics | 283.79B |
| S.Biomedics | 231.60B |
| Kangstem Biotech | 213.03B |
| NIBEC | 169.27B |
| Ensol Biosciences | 165.53B |
| Genome & Company | 163.77B |
| Kanaph Therapeutics | 161.96B |
| Y-Biologics | 153.30B |